Results of a recent study have shown the validity and reliability of the St George’s Respiratory Questionnaire (SGRQ) as a sensitive measure for capturing health-related quality of life (HRQoL) in patients with connective tissue disease-associated interstitial lung disease (CTD-ILD).
Patients with malignant airway obstruction (MAO) appear to have better survival with combination therapy with stenting plus external beam radiotherapy (EBRT) compared to stenting or EBRT alone, according to the results of a retrospective analysis.
High-grade adverse event (AEs) are relatively common in elderly adults with advanced or metastatic nonsmall cell lung cancer (NSCLC) treated with nivolumab in routine practice, a recent investigation has shown.
Digital mindfulness is an acceptable nonpharmacological intervention that can be integrated with existing treatment for patients with asthma to improve quality of life, according to a study from the UK reported at the recent European Respiratory Society (ERS) International Congress 2018.
The anti–interleukin-5 (anti–IL-5) agent reslizumab significantly improves disease control and lung function and reduces the need for oral steroid maintenance therapy in patients with severe eosinophilic asthma, results of a real-life study have shown.
Interstitial lung abnormalities (ILA), a common finding in low-dose chest CT, are associated with a 5.5-fold increase in risk of lung cancer over long-term follow-up, according to a study reported at the European Respiratory Society (ERS) International Congress 2018.
A simple instrument that uses thermistor-based breathing sensors can accurately measure respiratory rate (RR) in children, as well as in adults, holding great potential for diagnosing paediatric pneumonia in low-resource settings, according to a study.
Patients admitted to the intensive care unit (ICU) with severe influenza have an elevated risk of developing invasive pulmonary aspergillosis, particularly if they are immunocompromised at time of admission, a recent study has shown.
An investigational device monitoring fluid accumulation in the lungs significantly reduced hospitalization due to heart failure and death by any cause among heart failure patients compared with standard monitoring and treatment methods, according to results from the IMPEDANCE-HF trial reported during the recent ACC meeting in Chicago, Illinois, US.